FDA Siege | Debiased AI | Inpatient Screening
“We cannot allow unregulated AI to make clinical decisions.” Hardian Health’s Dr. Hugh Harvey in response to the FDA’s move to waive regulatory approval requirements for…
No AI Resistance
“This is not going to be a resistance kind of thing . . .” Stanford’s Matthew Lungren, MD MPH on radiologists’ growing embrace of AI (definitely…
AI Faceoff | COVID in the CT | Radres Handhelds
“A little knowledge, so the saying goes, can be a dangerous thing.” Signify Research’s Alan Stoddart on the potential pitfalls of ultrasound simplification and home adoption.…
Big Get Bigger | PoC MRI Works | Rogue LCS
“This is a milestone day.” Radiology Partners CEO, Rich Whitney, on the significance of RP’s acquisition of Mednax Radiology Solutions. Happy 250th Imaging Wire issue, everyone.…
AI Promises and Pitfalls | COVID Impact
“Accountants have known this for years. They use calculators, which you could think of is as a simplistic form of AI, to help them remedy their…
Mammography Evidence | Rads Ready to Reopen
“. . . the irony is that they get more money because they’re more dishonest,” Harvard professor, Malcolm Sparrow, on how some of the leading COVID-19…
Empathy Test | Perspectives on Transparency | Mammography Slowdown
“I have no idea what any of this ‘transparency’ will actually accomplish. My hope is that it will help to enlighten the fact that private pay…
Big AI Investments | Specialist Faceoff | AI’s Med Student Impact
“This is not peanuts.” Philips CEO, Frans van Houten, on the $69 million profit hit the company is expecting in 2019 as a result of the…
